Schedule 13G ownership disclosure
Haemonetics Corp
Security class unavailable · CUSIP: 405024100
Event date: 2019-02-28
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 5,780,122
- Percent of class
- 11.3300%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902219-19-000409
- Form type
- SC 13G
- Filer
- HAEMONETICS CORP
- CIK
- CIK 313143
- Filed
- Mar 11, 2019
- Reporting period
- Feb 28, 2019
- Description
- Schedule 13G beneficial ownership